Sam Myers

Sam Myers is a Senior Molecular Biologist at Epitopea since September 2024, previously serving as a Senior Scientist at Mogrify from February 2020 to September 2024, where Sam focused on developing novel transcription factor validation strategies, establishing vector quality control processes, and providing technical expertise in gene editing and iPSC management. Prior experience includes roles as Scientist II at Horizon Discovery, specializing in CRISPR/Cas9 gene editing and project management, and as a Research Associate at the University of Cambridge. Sam holds a PhD in Stem Cell Biology from the University of Cambridge and a Master's degree in Medical Biosciences from the University of Bath.